FDA Device Chief Issues Caution On 510(k)s: Data Requests Could Get Steeper
FDA will demand more comprehensive data from a growing subset of 510(k) submissions, CDRH Director Daniel Schultz suggested at a recent industry meeting
FDA will demand more comprehensive data from a growing subset of 510(k) submissions, CDRH Director Daniel Schultz suggested at a recent industry meeting